NO740546L - Analogifremgangsmåte til fremstilling av terapeutisk virksomme tripeptider. - Google Patents

Analogifremgangsmåte til fremstilling av terapeutisk virksomme tripeptider.

Info

Publication number
NO740546L
NO740546L NO740546A NO740546A NO740546L NO 740546 L NO740546 L NO 740546L NO 740546 A NO740546 A NO 740546A NO 740546 A NO740546 A NO 740546A NO 740546 L NO740546 L NO 740546L
Authority
NO
Norway
Prior art keywords
tripeptides
preparation
therapeutically effective
analogous process
analogous
Prior art date
Application number
NO740546A
Other languages
English (en)
Other versions
NO141262C (no
NO141262B (no
Inventor
Chitoshi Hatanaka
Masahiko Fujino
Tsunehiko Fukuda
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of NO740546L publication Critical patent/NO740546L/no
Publication of NO141262B publication Critical patent/NO141262B/no
Publication of NO141262C publication Critical patent/NO141262C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO740546A 1973-02-23 1974-02-19 Analogifremgangsmaate til fremstilling av terapeutisk virksomme tripeptider NO141262C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2254473A JPS5714337B2 (no) 1973-02-23 1973-02-23

Publications (3)

Publication Number Publication Date
NO740546L true NO740546L (no) 1974-08-26
NO141262B NO141262B (no) 1979-10-29
NO141262C NO141262C (no) 1980-02-06

Family

ID=12085750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740546A NO141262C (no) 1973-02-23 1974-02-19 Analogifremgangsmaate til fremstilling av terapeutisk virksomme tripeptider

Country Status (15)

Country Link
US (1) US3912705A (no)
JP (1) JPS5714337B2 (no)
AT (1) AT335085B (no)
AU (1) AU475886B2 (no)
BE (1) BE811467A (no)
CA (1) CA1032934A (no)
CH (1) CH594609A5 (no)
DE (1) DE2408324A1 (no)
FR (1) FR2219154B1 (no)
GB (1) GB1434147A (no)
HK (1) HK15479A (no)
HU (1) HU170645B (no)
NL (1) NL7402487A (no)
NO (1) NO141262C (no)
SE (1) SE400074B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
SE408300B (sv) * 1974-10-16 1979-06-05 Gruenenthal Chemie Sett att framstella nya dipeptidderivat
AU504840B2 (en) 1975-09-09 1979-11-01 Takeda Chemical Industries Ltd Medicinal compositions
AU4125578A (en) * 1977-11-09 1979-05-17 Merck & Co Inc Tripeptides
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
JPS59155346A (ja) * 1983-02-24 1984-09-04 Itsuro Sofue ペプタイド
JPS60190795A (ja) * 1984-03-09 1985-09-28 Takeda Chem Ind Ltd ペプタイド
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
BR112016025076B1 (pt) * 2014-04-30 2022-03-03 Syngenta Participations Ag Processo para a preparação de ciclosserinas substituídas e seus compostos
IL317108A (en) * 2022-05-30 2025-01-01 Syngenta Crop Protection Ag Process for preparing 4-SUBSTITUTED 2-OXAZOLIDINONES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides

Also Published As

Publication number Publication date
AU6584474A (en) 1975-08-21
FR2219154B1 (no) 1978-01-06
NO141262C (no) 1980-02-06
JPS5714337B2 (no) 1982-03-24
NO141262B (no) 1979-10-29
AU475886B2 (en) 1976-09-09
BE811467A (fr) 1974-08-22
CA1032934A (en) 1978-06-13
CH594609A5 (no) 1978-01-13
ATA138074A (de) 1976-06-15
HK15479A (en) 1979-03-30
JPS49108075A (no) 1974-10-14
NL7402487A (no) 1974-08-27
US3912705A (en) 1975-10-14
DE2408324A1 (de) 1974-08-29
SE400074B (sv) 1978-03-13
HU170645B (no) 1977-07-28
GB1434147A (en) 1976-05-05
AT335085B (de) 1977-02-25
FR2219154A1 (no) 1974-09-20

Similar Documents

Publication Publication Date Title
NO740272L (no) Analogifremgangsmåte til fremstilling av 3-substituerte 4-fenylpiperidiner.
NO145273C (no) N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO740675L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme dotriacontapeptidamider.
NO740546L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme tripeptider.
NO741223L (no) Fremgangsmåte for fremstilling av 6-deoksytetracykliner.
NO740327L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive imidazopyridiner.
NO741607L (no) Fremgangsmåte for fremstilling av isocyanater.
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
NO740405L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater.
NO741364L (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser.
DK137389B (da) Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener.
NO740614L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser.
NO741350L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive benzylaminer.
DK133977B (da) Fremgangsmåde til fremstilling af 2-chlor-5-sulfamoylbenzoesyrer.
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.
FI51098C (fi) Menetelmä terapeuttisesti arvokkaan 2-okso-1-pyrrolidinyyliasetamidin valmistamiseksi.
NO740779L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 6-substituerte 3-karbetoksyhydrazinopyridaziner.
NO741309L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive seco-prostaglandiner.
NO741044L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive triaziner.
NO141162C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-okso-2-imidazolidinyliden-urinstoffer
NO740486L (no) Analogifremgangsmåte til fremstilling av beta-reseptor-aktive forbindelser.
NO741141L (no) Analogifremgangsmåte ved fremstilling av nye terapeutisk aktive benzopyranopyridinderivater.
NO741844L (no) Analogifremgangsmåte til fremstilling av beta-adrenergisk blokkerende aminopropanoler.